News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
229 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17856)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (331)
2 (134)
3 (3)
4 (4)
5 (239)
6 (297)
7 (254)
8 (229)
9 (142)
10 (7)
11 (9)
12 (228)
13 (282)
14 (268)
15 (254)
16 (160)
17 (2)
18 (5)
19 (218)
20 (259)
21 (132)
22 (18)
23 (29)
24 (4)
25 (14)
26 (221)
27 (273)
28 (265)
29 (229)
30 (119)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
Regulus Reports Third Quarter 2018 Financial Results and Recent Updates
$47 Million Restructured Sanofi Collaboration Executed
November 8, 2018
·
10 min read
Myovant Provides Corporate Updates and Reports Financial Results for Second Fiscal Quarter Ended September 30, 2018
Completed Patient Enrollment in Phase 3 LIBERTY 1 and HERO Trials
November 8, 2018
·
11 min read
Biotech Beach
Tandem Diabetes Care Announces Upcoming November 2018 Conference Presentations
Tandem Diabetes Care®, Inc. today announced that management will present at the following upcoming investor conferences
November 8, 2018
·
2 min read
Business
Natera Reports Third Quarter 2018 Financial Results
Natera, Inc. today reported financial results for the third quarter ended September 30, 2018, and provided an update on recent business progress.
November 8, 2018
·
14 min read
Deals
Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) on November 6, 2018
Endologix, Inc. announced today the grant of inducement equity awards to three newly hired employees (together, the “Awardees”).
November 8, 2018
·
1 min read
Business
Spectrum Pharmaceuticals Reports Third Quarter 2018 Pipeline Update and Financial Results
Poziotinib interim data from the MD Anderson Phase 2 study presented in Q3 demonstrated strong efficacy in metastatic, heavily pretreated EGFR and HER2 exon 20 mutations in NSCLC patients
November 8, 2018
·
17 min read
Business
Versant Health Expands Its National Sales Team
Versant Heal continues to grow its national sales team with two regional executives: Kristen Gutierrez and Brett Cavallaro.
November 8, 2018
·
1 min read
Business
Omeros Corporation Reports Third Quarter 2018 Financial Results
Conference Call Friday, November 9th at 8:30 a.m. ET
November 8, 2018
·
15 min read
Business
Synthetic Biologics Reports Third Quarter 2018 Operational Highlights and Financial Results
Announced Agreement with Cedars-Sinai Medical Center to Co-fund a Phase 2b Investigator-Sponsored Clinical Study of SYN-010, for the Treatment of IBS-C
November 8, 2018
·
13 min read
Business
American Renal Associates Holdings, Inc. Announces Third Quarter 2018 Results
American Renal Associates Holdings, Inc. today announced financial and operating results for the third quarter ended September 30, 2018.
November 8, 2018
·
37 min read
Previous
12 of 23
Next